Thieler Law Corp advises investors with losses exceeding $100,000 of the October 31, 2016 lead plaintiff deadline in a class action lawsuit filed against American Renal Associates Holdings Inc (NYSE: ARA) (“American Renal” or “the Company”). The suit is pending in the U.S. District Court for the Southern District of New York and investors, who purchased American Renal Associates Holdings Inc securities between April 21, 2016 and August 18, 2016, have until October 31, 2016 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased American Renal Associates Holdings Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that American Renal was engaged in a fraudulent scheme to steer patients away from qualified-for Medicare and Medicaid plans into more expensive Affordable Care Act plans to obtain greater reimbursement for American Renal's dialysis services; the foregoing scheme was in violation of federal and state laws; and as a result, American Renal's public statements were materially false and misleading at all relevant times.

On July 1, 2016, three insurance companies filed a lawsuit against American Renal and an affiliated, claiming that the Company was engaged in a “fraudulent and illegal scheme” that involved persuading patients who qualified for Medicare or Medicaid coverage to enroll in commercial healthcare plans and then connecting those patients with American Renal.

On August 18, 2016, the Centers for Medicare and Medicaid Services, a federal agency within the U.S. Department of Health and Human Services, revealed that it had sent warning letters to all dialysis centers that partake in the federal Medicare program. Also, the agency stated that it is considering financial penalties on providers found to have directed people eligible for Medicare into Affordable Care Act plans instead.

Following this news, NYSE: ARA dropped in value, causing investors harm.

If you were negatively impacted by your investment in American Renal Associates Holdings Inc securities between April 21, 2016 and August 18, 2016 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185